Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars

Mashhad University of Medical Sciences

Status and phase: Unknown; Phase 4

Conditions: Dental Pulp Disease; Pulpitis; Tooth Diseases

Treatments: Drug: Formocresol; Drug: Mineral Trioxide Aggregate

Study type: Interventional

Funder types: Other

Identifiers

NCT02286648

921762

Details and patient eligibility

About

The purpose of this study is to evaluate the clinical and radiographic success rate of Miniature pulpotomy with Mineral Trioxide Aggregate (MTA) in primary molars.

Enrollment: 50 estimated patients

Sex: All

Ages: 4 to 7 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy people(without any systemic disease)

• teeth :

  • no clinical or radiographic evidence of pulp degeneration
  • the possibility of proper restoration of the teeth

Exclusion criteria

• teeth :

  • excessive bleeding from the exposure site
  • internal root resorption
  • interradicular and/or periapical bone destruction
  • swelling or sinus tract

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

50 participants in 2 patient groups

Mineral Trioxide Aggregate

Experimental group

Description:

pulpotomy with MTA

Treatment:

Drug: Mineral Trioxide Aggregate

Formocresol

Active Comparator group

Description:

pulpotomy with FC

Treatment:

Drug: Formocresol